Biglycan (December 2011) Biglycan as a protein therapeutic for Duchenne Muscular Dystrophy Justin R. Fallon, Department of Neuroscience, Brown University Research & Clinical Trial Webinars,Webinars 13 years ago You may also like 1:03:41 Community Update with Solid Biosciences on the New INSPIRE DUCHENNE Clinical Study of SGT-003 8 months ago Research & Clinical Trial Webinars,Webinars gene therapy,sgt-003,solid biosciences 1:00:42 AGAMREE® Approval with Catalyst Pharmaceuticals, Inc. 8 months ago Care Webinars,Webinars agamree,catalyst,vamorolone 59:54 Overview of Topline Results from Phase 3 EMBARK Study 9 months ago Research & Clinical Trial Webinars,Webinars sarepta 50:51 AGAMREE Approval: What this means for you and your family 9 months ago Care Webinars,Webinars 25:01 Advocating for Access: Overview of Medicaid DUR and P&T Meetings 9 months ago Care Webinars,Webinars feature,insurance,medicaid 54:28 Capricor Therapeutics: CAP-1002 HOPE-3 Program Update 9 months ago Research & Clinical Trial Webinars,Webinars capricor 49:31 Edgewise Therapeutics: A Novel Approach Designed to Protect Muscle in Becker Muscular Dystrophy 9 months ago Research & Clinical Trial Webinars,Webinars edg-5506,edgewise 59:38 Supporting Families Through Decision Making 9 months ago Care Webinars,Webinars palliative care «1234…24»Page 2 of 24
by: Parent Project Muscular Dystrophy
